knockout_mice
Bluelighter
- Joined
- Mar 3, 2012
- Messages
- 69
I've always been fascinated by the stimulant effects of Kratom, and I'm curious about the pharmacodynamics behind it. I realize that other opioids can also have a stimulant effect, especially after tolerance sets in:
Excerpt from "The pharmacology and toxicology of kratom: from traditional herb to drug of abuse":
From "Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract":
I'm looking forward to hear your theories. Kratom might pave the way to more gentle stimulants in the future.
- One such example is Tramadol, but the pharmacology there is pretty clear: it's also an SNRI.
- Tianeptine is a weirder example because it's a selective mu-opioid agonist. (Funnily, it was kept as a "secret" by Servier. They did a huge receptor screening and somehow forgot to test opioid receptors. Honest mistake?) It shows that a selective opioid agonist can also have a somewhat stimulating effect without other known receptor interactions.
Excerpt from "The pharmacology and toxicology of kratom: from traditional herb to drug of abuse":
Mitragynine and 7-HMG are selective and full agonists of μ-opioid subtype receptors [3, 7, 8, 21]. Mitragynine exhibit sactivity on supraspinal μ- and δ-opioid receptors causing its characteristic analgesic effects [3, 7, 8, 21]. With consideration to the interactions at the cellular level, studies suggest that neurotransmitter release from the nerve endings at the vasdeferens is inhibited [21]. This inhibition is suggested to occur through the obstruction of neuronal calcium (Ca2+) channels[7, 22].
Blocked stimulation of serotonergic 5-HT2A receptors and stimulation of postsynaptic alpha-2 adrenergic receptors are thought to contribute to stimulant activity [3, 8].Additional psychoactivity is said to exist as a consequence of binding affinities exceeding that of morphine at the δ- and κ- opioid central receptors [21]. Moreover, 7-HMG provides high opioid receptor affinity with full agonist properties [8,21]. While polarity is increased due to the additional hydroxylgroup on 7-HMG as compared to mitragynine, increased activity of 7-HMG is otherwise not well understood [21].
From "Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract":
The effect of kratom on MOR is quantitatively different to that of morphine, the affinity is less, and kratom was not able to induce a comparable phosphorylation (Fig. 9) and signal induction of MOR (GTPγS stimulation, Fig. 8). The effect of kratom is less pronounced, and in comparison to the specific μ-opioid agonists, it is about two orders of magnitude less potent. In addition to MOR binding, the extract also binds to DOR, KOR, and dopamine D1 receptors
I'm looking forward to hear your theories. Kratom might pave the way to more gentle stimulants in the future.
